| scholarly article | Q13442814 |
| P356 | DOI | 10.1176/APPI.PSY.43.3.175 |
| P8608 | Fatcat ID | release_c7d7xoc6bzctrasrfjdkecuuoq |
| P698 | PubMed publication ID | 12075032 |
| P5875 | ResearchGate publication ID | 11299989 |
| P2093 | author name string | Annie Tremblay | |
| Christopher Gibson | |||
| William Breitbart | |||
| P433 | issue | 3 | |
| P921 | main subject | delirium | Q160796 |
| patient | Q181600 | ||
| hospitalization | Q3140971 | ||
| P304 | page(s) | 175-182 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Psychosomatics | Q7256494 |
| P1476 | title | An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients | |
| P478 | volume | 43 |
| Q39175922 | A Review of Agents for Palliative Sedation/Continuous Deep Sedation: Pharmacology and Practical Applications |
| Q44962179 | A double-blind trial of risperidone and haloperidol for the treatment of delirium |
| Q55021143 | A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea. |
| Q36734720 | Altered mental status in older patients in the emergency department |
| Q38682595 | An integrative literature review exploring the clinical management of delirium in patients with advanced cancer. |
| Q37959135 | An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients |
| Q37172060 | An update on the use of antipsychotics in the treatment of delirium |
| Q56140928 | Antipsychotics for treatment of delirium in hospitalised non-ICU patients |
| Q37957117 | Antipsychotics in the treatment of delirium in older hospitalized adults: a systematic review |
| Q39767297 | Atypical antipsychotics for the treatment of ICU delirium |
| Q36440224 | Atypical antipsychotics in the management of delirium: a review of the empirical literature |
| Q37578768 | Atypical antipsychotics in the treatment of delirium |
| Q38121987 | Atypical antipsychotics in the treatment of delirium |
| Q45927709 | Blonanserin in the treatment of delirium. |
| Q35200049 | Clinical pharmacology of old age syndromes |
| Q34434241 | Clinical subtypes of delirium and their relevance for daily clinical practice: a systematic review |
| Q53840260 | Comparison of efficacy of haloperidol and olanzapine in the treatment of delirium. |
| Q37435834 | Comprehensive approaches to managing delirium in patients with advanced cancer |
| Q78344719 | Current awareness in geriatric psychiatry |
| Q48322850 | Debate article: Antipsychotic medications are clinically useful for the treatment of delirium |
| Q37590698 | Delirium and antipsychotics: a systematic review of epidemiology and somatic treatment options. |
| Q22305822 | Delirium and its Treatment |
| Q41361406 | Delirium associated with olanzapine therapy in an elderly male with bipolar affective disorder |
| Q38732544 | Delirium clinical motor subtypes: a narrative review of the literature and insights from neurobiology |
| Q33925658 | Delirium in advanced age and dementia: A prolonged refractory course of delirium and lower functional status. |
| Q35805731 | Delirium in advanced cancer patients |
| Q37121627 | Delirium in hospitalised older persons: review. |
| Q38245308 | Delirium in patients with cancer: assessment, impact, mechanisms and management. |
| Q37004135 | Delirium in the older emergency department patient: a quiet epidemic |
| Q47187466 | Delirium subtype identification and the validation of the Delirium Rating Scale--Revised-98 (Dutch version) in hospitalized elderly patients |
| Q35696676 | Delirium: current trends in prevention and treatment |
| Q52596148 | Delirium: pathophysiology, recognition, prevention and treatment. |
| Q47592744 | Delirium: underrecognized and undertreated |
| Q37225941 | Delirium: where do we stand? |
| Q35237260 | Depression and end-of-life care for patients with cancer |
| Q24197552 | Drug therapy for delirium in terminally ill adult patients |
| Q24247148 | Drug therapy for delirium in terminally ill adult patients |
| Q35001436 | Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium |
| Q37796552 | Evidence-Based Approaches to Other Symptoms in Advanced Cancer |
| Q36822176 | Evidence-based treatment of delirium in patients with cancer |
| Q37679321 | Factors associated with prolonged delirium: a systematic review |
| Q44462921 | Flushing and sweating in an advanced breast cancer patient relieved by olanzapine |
| Q28267046 | Haloperidol in palliative care |
| Q84009806 | Impact of an educational workshop upon attitudes towards pharmacotherapy for delirium |
| Q35216419 | Impaired communication capacity and agitated delirium in the final week of terminally ill cancer patients: prevalence and identification of research focus |
| Q50129426 | Intensive Care Unit delirium: A wide gap between actual prevalence and psychiatric referral |
| Q90675062 | JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements |
| Q39266110 | Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients |
| Q35557971 | Management of delirium in palliative care: a review |
| Q24195013 | Medically assisted hydration for adult palliative care patients |
| Q24242918 | Medically assisted hydration for adult palliative care patients |
| Q34945773 | Motor subtypes of delirium: past, present and future |
| Q90257602 | Olanzapine Versus Haloperidol for Treatment of Delirium in Patients with Advanced Cancer: A Phase III Randomized Clinical Trial |
| Q44462934 | Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer |
| Q44699605 | Olanzapine vs haloperidol: treating delirium in a critical care setting |
| Q38001959 | Olanzapine: palliative medicine update |
| Q37382797 | Palliating delirium in patients with cancer |
| Q51938746 | Palliative care: an opportunity for mental health professionals. |
| Q46730298 | Perioperative care of palliative patients by the anesthetist : medical, psychosocial and ethical challenges |
| Q42609563 | Perospirone in the treatment of patients with delirium |
| Q86414259 | Pharmacological treatment of delirium in palliative care patients. A systematic literature review |
| Q40689160 | Phenomenology of delirium among patients admitted to a coronary care unit |
| Q40621814 | Preventing Delirium at the End of Life: Lessons From Recent Research |
| Q44714322 | Psychiatric considerations in the patient receiving organ transplantation: a clinical case conference |
| Q35579736 | Psychiatric issues in older cancer patients |
| Q35772834 | Psychotic symptoms in patients with medical disorders |
| Q43045537 | Risperidone versus olanzapine for the treatment of delirium |
| Q36329212 | Sedation and analgesia-prescribing patterns in terminally ill patients at the end of life |
| Q36626321 | Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients |
| Q36440129 | The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response |
| Q36428490 | The management of behavioural and psychiatric symptoms in delirium |
| Q38677762 | The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting |
| Q33844380 | Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development |
| Q44506450 | Treatment for delirium with risperidone: results of a prospective open trial with 10 patients |
| Q38290683 | Use of aripiprazole for delirium in the elderly: a short review |
| Q49519035 | Validation of the Korean Version of the Delirium Motor Subtype Scale |
| Q56775215 | [Informed Consent and the Approval by Ethics Committees of Studies Involving the Use of Atypical Antipsychotics in the Management of Delirium] |
Search more.